Chenan Zhang1, Libby M Morimoto2, Adam J de Smith1, Helen M Hansen3, Julio Gonzalez-Maya3, Alyson A Endicott3, Ivan V Smirnov3, Catherine Metayer2, Qingyi Wei4, William C Eward5, Joseph L Wiemels1,6, Kyle M Walsh1,7,8. 1. Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California. 2. School of Public Health, University of California at Berkeley, Berkeley, California. 3. Department of Neurological Surgery, University of California at San Francisco, San Francisco, California. 4. Department of Population Health Sciences, Duke University, Durham, North Carolina. 5. Department of Orthopedic Surgery, Duke University, Durham, North Carolina. 6. Center for Genetic Epidemiology, University of Southern California, Los Angeles, California. 7. Department of Neurosurgery, Duke University, Durham, North Carolina. 8. Children's Health and Discovery Institute, Duke University, Durham, North Carolina.
Abstract
BACKGROUND: Although increased height has been associated with osteosarcoma risk in previous epidemiologic studies, to the authors' knowledge the relative contribution of stature during different developmental timepoints remains unclear. Furthermore, the question of how genetic determinants of height impact osteosarcoma etiology remains unexplored. Genetic variants associated with stature in previous genome-wide association studies may be biomarkers of osteosarcoma risk. METHODS: The authors tested the associations between osteosarcoma risk and polygenic scores for adult height (416 variants), childhood height (6 variants), and birth length (5 variants) in 864 osteosarcoma cases and 1879 controls of European ancestry. RESULTS: Each standard deviation increase in the polygenic score for adult height, corresponding to a 1.7-cm increase in stature, was found to be associated with a 1.10-fold increase in the risk of osteosarcoma (95% confidence interval [95% CI], 1.01-1.19; P =.027). Each standard deviation increase in the polygenic score for childhood height, corresponding to a 0.5-cm increase in stature, was associated with a 1.10-fold increase in the risk of osteosarcoma (95% CI, 1.01-1.20; P =.023). The polygenic score for birth length was not found to be associated with osteosarcoma risk (P =.11). When adult and childhood height scores were modeled together, they were found to be independently associated with osteosarcoma risk (P =.037 and P = .043, respectively). An expression quantitative trait locus for cartilage intermediate layer protein 2 (CILP2), rs8103992, was significantly associated with osteosarcoma risk after adjustment for multiple comparisons (odds ratio, 1.35; 95% CI, 1.16-1.56 [P = 7.93×10-5 and Padjusted =.034]). CONCLUSIONS: A genetic propensity for taller adult and childhood height attainments contributed independently to osteosarcoma risk in the current study data. These results suggest that the biological pathways affecting normal bone growth may be involved in osteosarcoma etiology.
BACKGROUND: Although increased height has been associated with osteosarcoma risk in previous epidemiologic studies, to the authors' knowledge the relative contribution of stature during different developmental timepoints remains unclear. Furthermore, the question of how genetic determinants of height impact osteosarcoma etiology remains unexplored. Genetic variants associated with stature in previous genome-wide association studies may be biomarkers of osteosarcoma risk. METHODS: The authors tested the associations between osteosarcoma risk and polygenic scores for adult height (416 variants), childhood height (6 variants), and birth length (5 variants) in 864 osteosarcoma cases and 1879 controls of European ancestry. RESULTS: Each standard deviation increase in the polygenic score for adult height, corresponding to a 1.7-cm increase in stature, was found to be associated with a 1.10-fold increase in the risk of osteosarcoma (95% confidence interval [95% CI], 1.01-1.19; P =.027). Each standard deviation increase in the polygenic score for childhood height, corresponding to a 0.5-cm increase in stature, was associated with a 1.10-fold increase in the risk of osteosarcoma (95% CI, 1.01-1.20; P =.023). The polygenic score for birth length was not found to be associated with osteosarcoma risk (P =.11). When adult and childhood height scores were modeled together, they were found to be independently associated with osteosarcoma risk (P =.037 and P = .043, respectively). An expression quantitative trait locus for cartilage intermediate layer protein 2 (CILP2), rs8103992, was significantly associated with osteosarcoma risk after adjustment for multiple comparisons (odds ratio, 1.35; 95% CI, 1.16-1.56 [P = 7.93×10-5 and Padjusted =.034]). CONCLUSIONS: A genetic propensity for taller adult and childhood height attainments contributed independently to osteosarcoma risk in the current study data. These results suggest that the biological pathways affecting normal bone growth may be involved in osteosarcoma etiology.
Authors: Alyson A Endicott; Libby M Morimoto; Cassie N Kline; Joseph L Wiemels; Catherine Metayer; Kyle M Walsh Journal: Pediatr Blood Cancer Date: 2016-11-10 Impact factor: 3.167
Authors: Ramandeep S Arora; Evangelos Kontopantelis; Robert D Alston; Tim O Eden; Marco Geraci; Jillian M Birch Journal: Cancer Causes Control Date: 2011-02-19 Impact factor: 2.506
Authors: E I Hauben; J Arends; J P Vandenbroucke; C J van Asperen; E Van Marck; P C W Hogendoorn Journal: Eur J Hum Genet Date: 2003-08 Impact factor: 4.246
Authors: Shane McCarthy; Sayantan Das; Warren Kretzschmar; Olivier Delaneau; Andrew R Wood; Alexander Teumer; Hyun Min Kang; Christian Fuchsberger; Petr Danecek; Kevin Sharp; Yang Luo; Carlo Sidore; Alan Kwong; Nicholas Timpson; Seppo Koskinen; Scott Vrieze; Laura J Scott; He Zhang; Anubha Mahajan; Jan Veldink; Ulrike Peters; Carlos Pato; Cornelia M van Duijn; Christopher E Gillies; Ilaria Gandin; Massimo Mezzavilla; Arthur Gilly; Massimiliano Cocca; Michela Traglia; Andrea Angius; Jeffrey C Barrett; Dorrett Boomsma; Kari Branham; Gerome Breen; Chad M Brummett; Fabio Busonero; Harry Campbell; Andrew Chan; Sai Chen; Emily Chew; Francis S Collins; Laura J Corbin; George Davey Smith; George Dedoussis; Marcus Dorr; Aliki-Eleni Farmaki; Luigi Ferrucci; Lukas Forer; Ross M Fraser; Stacey Gabriel; Shawn Levy; Leif Groop; Tabitha Harrison; Andrew Hattersley; Oddgeir L Holmen; Kristian Hveem; Matthias Kretzler; James C Lee; Matt McGue; Thomas Meitinger; David Melzer; Josine L Min; Karen L Mohlke; John B Vincent; Matthias Nauck; Deborah Nickerson; Aarno Palotie; Michele Pato; Nicola Pirastu; Melvin McInnis; J Brent Richards; Cinzia Sala; Veikko Salomaa; David Schlessinger; Sebastian Schoenherr; P Eline Slagboom; Kerrin Small; Timothy Spector; Dwight Stambolian; Marcus Tuke; Jaakko Tuomilehto; Leonard H Van den Berg; Wouter Van Rheenen; Uwe Volker; Cisca Wijmenga; Daniela Toniolo; Eleftheria Zeggini; Paolo Gasparini; Matthew G Sampson; James F Wilson; Timothy Frayling; Paul I W de Bakker; Morris A Swertz; Steven McCarroll; Charles Kooperberg; Annelot Dekker; David Altshuler; Cristen Willer; William Iacono; Samuli Ripatti; Nicole Soranzo; Klaudia Walter; Anand Swaroop; Francesco Cucca; Carl A Anderson; Richard M Myers; Michael Boehnke; Mark I McCarthy; Richard Durbin Journal: Nat Genet Date: 2016-08-22 Impact factor: 38.330
Authors: Eleanor C Semmes; Jayaram Vijayakrishnan; Chenan Zhang; Jillian H Hurst; Richard S Houlston; Kyle M Walsh Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-05-28 Impact factor: 4.254
Authors: Gabriela A Rojas; Aubrey K Hubbard; Brandon J Diessner; Karina B Ribeiro; Logan G Spector Journal: Int J Cancer Date: 2021-05-17 Impact factor: 7.316
Authors: Eleanor C Semmes; Erica Shen; Jennifer L Cohen; Chenan Zhang; Qingyi Wei; Jillian H Hurst; Kyle M Walsh Journal: Cancer Med Date: 2020-09-17 Impact factor: 4.452
Authors: Jonathan D Nilles; Dooyoung Lim; Michael P Boyer; Brittany D Wilson; Rebekah A Betar; Holly A Showalter; Darren Liu; Elitsa A Ananieva Journal: Environ Geochem Health Date: 2022-04-05 Impact factor: 4.609
Authors: Chenan Zhang; Quinn T Ostrom; Eleanor C Semmes; Vijay Ramaswamy; Helen M Hansen; Libby Morimoto; Adam J de Smith; Melike Pekmezci; Zalman Vaksman; Hakon Hakonarson; Sharon J Diskin; Catherine Metayer; Michael D Taylor; Joseph L Wiemels; Melissa L Bondy; Kyle M Walsh Journal: Acta Neuropathol Commun Date: 2020-10-28 Impact factor: 7.578